Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies
December 12, 2023 07:00 ET
|
Athira Pharma, Inc.
Exploratory findings add to increasing body of clinical and preclinical data supporting positive modulation of the neurotrophic HGF system as a potential therapeutic approach for neurodegenerative...
Athira Pharma Presents Phase 2 Clinical Data Correlating Improvements in Biomarkers of Neurodegeneration and Neuroinflammation with Improvements in Measures of Cognition and Function in Alzheimer’s Disease
July 17, 2023 07:00 ET
|
Athira Pharma, Inc.
New preclinical data demonstrate neuroprotective effects of fosgonimeton in models of amyloid-ß-mediated toxicity In preclinical models, ATH-1105 protects against pathologies common to amyotrophic...
DEADLINE ALERT for TEDU and ATHA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
August 23, 2021 12:00 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Aug. 23, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ATHA FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Athira Pharma, Inc. Investors to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – ATHA
August 20, 2021 16:57 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 20, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athira Pharma, Inc. (NASDAQ: ATHA): (a) pursuant and/or...
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Athira Pharma, Inc. Investors With Losses Over $100K to Secure Counsel Before Important August 24 Deadline in Securities Class Action – ATHA
August 17, 2021 15:30 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athira Pharma, Inc. (NASDAQ: ATHA): (a) pursuant and/or...
DEADLINE ALERT for OCGN, HMPT, TEDU, and ATHA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
August 16, 2021 11:40 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Los Angeles -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for OCGN, HMPT, TEDU, and ATHA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
August 09, 2021 11:30 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Athira Pharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ATHA
August 06, 2021 12:45 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athira Pharma, Inc. (NASDAQ: ATHA): (a) pursuant...
DEADLINE ALERT for OCGN, TEDU, ATHA, REKR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
August 03, 2021 12:00 ET
|
Law Offices of Howard G. Smith
BENSALEM, Pa., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for OCGN, HMPT, TEDU, and ATHA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
August 02, 2021 11:05 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Aug. 02, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...